Results 1 to 10 of about 448,635 (294)

A hierarchical competing risks survival model in the study of child mortality in Bangladesh

open access: yesScientific Reports
Under-five child mortality remains a significant public health issue in Bangladesh and other developing countries. Identifying key risk factors within a hierarchical data structure is crucial for improving health system performance.
Nazmul Haque   +3 more
doaj   +1 more source

Cumulative incidence function estimation using population-based biobank data

open access: yesBiometrics
ABSTRACT Many countries have established population-based biobanks, which are being used increasingly in epidemiological and clinical research. These biobanks offer opportunities for large-scale studies addressing questions beyond the scope of traditional clinical trials or cohort studies. However, using biobank data poses new challenges.
Malka Gorfine   +2 more
openaire   +1 more source

Methods of competing risks analysis of time to occurrence of reflux among children with antenatal hydronephrosis

open access: yesJournal of Biostatistics and Epidemiology, 2016
Background & Aim: We aimed to describe a standard survival analysis, so that we can analyze some factors related to the time of occurrence of different types of reflux (unilateral-left, unilateralright, and bilateral) in children with antenatal ...
Maryam Nazemipour   +6 more
doaj  

Evaluation and development of animal breeding in Ireland [PDF]

open access: yes, 2008
End of project reportThe primary objectives of this study were: 1) to annually evaluate the pertinence of the Irish dairy cattle breeding index, the Economic Breeding Index (EBI) and where necessary modify, 2) to evaluate the potential of do-it-yourself ...
Berry, Donagh   +2 more
core  

Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia

open access: yesBMC Infectious Diseases
Introduction Tuberculosis (TB) remains the most common opportunistic infection and leading cause of death among individuals living with HIV/AIDS in Ethiopia. Its significant impact on morbidity and mortality underscores the crucial link between these two
Tsegaye H. Kumssa   +3 more
doaj   +1 more source

Opening the black box: defining true-negative outcomes in esophageal cancer screening — a population-based study

open access: yesBMC Medicine
Background Current negativity definition in esophageal cancer screening overlooks the risk heterogeneity between individuals with non-dysplastic Lugol’s unstained lesions (ND-LULs) and normal-stained epithelium.
Mengfei Liu   +19 more
doaj   +1 more source

Identifiability and estimation of the sign of a covariate effect in the competing risks model. [PDF]

open access: yes
It is well known that the competing risks model is identified if the dependence structure between risks (the copula function) is known or assumed. Special cases include independence of risks or independent censoring.
Ralf A. Wilke, Simon M.S. Lo
core  

Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study

open access: yesCancer Medicine, 2019
This multicenter, prospective, observational cohort study assessed opioid induced constipation (OIC) in Japanese patients with cancer. Eligible patients had stable cancer and an ECOG PS of 0‐2.
Akihiro Tokoro   +8 more
doaj   +1 more source

Restricted estimation of the cumulative incidence functions corresponding to competing risks

open access: yes, 2006
In the competing risks problem, an important role is played by the cumulative incidence function (CIF), whose value at time $t$ is the probability of failure by time $t$ from a particular type of failure in the presence of other risks. In some cases there are reasons to believe that the CIFs due to various types of failure are linearly ordered.
El Barmi, Hammou, Mukerjee, Hari
openaire   +4 more sources

The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis

open access: yesRheumatology
Introduction Methotrexate (MTX) is a chemotherapy agent and immune system suppressant that can cause liver fibrosis in long-term usage. This study aimed to investigate the relationship between the dose of MTX and the incidence of liver fibrosis in ...
Mina AkbariRad   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy